iC BIOSOLUTIONS is proud to announce that we have successfully raised approximately €4 million through a series of strategic fundraising initiatives over the past two years. This achievement combines support from private investors and national-regional funding programs, reinforcing confidence in our vision and technology.
These resources are pivotal to advancing our innovative approach and accelerating the development of our lead candidate, ICB001. The sustained backing from both private and public partners highlights the strength of our long-term strategy and commitment to delivering transformative solutions in the biotech sector.
With this funding, iC BIOSOLUTIONS is well-positioned to reach key milestones and bring groundbreaking therapies closer to patients.
Stay connected for upcoming updates as we continue to drive innovation forward.